Filter Results :

Your search for Cancer Drug Market returned 113 reports

Sort by


Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021

29 Nov 2016  |  Published by:  MarketsandMarkets
The immunohistochemistry (IHC) market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period of 2016 to 2021. Factors such as the growing prevalence of cancer and rapidly increasing geriatric population across the globe are the primary driving the growth...

$ 5,650.00

Read More

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Breast Cancer-API Insights, 2015,report provides Breast Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countri...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Cancer Pain-API Insights, 2015,report provides Cancer Pain drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries r...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2015,report provides Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer drugs marketed details and API Manufacturers details across the globe along with t...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Lung Cancer-API Insights, 2015,report provides Lung Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries r...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Metastatic Prostate Cancer-API Insights, 2015,report provides Metastatic Prostate Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF ...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Non-Small Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Non-Small Cell Lung Cancer-API Insights, 2015,report provides Non-Small Cell Lung Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF ...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Ovarian Cancer-API Insights, 2015,report provides Ovarian Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide count...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Prostate Cancer-API Insights, 2015,report provides Prostate Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide cou...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Rectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Rectal Cancer-API Insights, 2015,report provides Rectal Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countri...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Bladder Cancer-API Insights, 2015,report provides Bladder Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide count...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Cervical Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Cervical Cancer-API Insights, 2015,report provides Cervical Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide cou...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Colon Cancer-API Insights, 2015,report provides Colon Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Colorectal Cancer-API Insights, 2015,report provides Colorectal Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Esophageal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Esophageal Cancer-API Insights, 2015,report provides Esophageal Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide...

$ 1,250.00
$ 875.00
( Save 30% )

Read More
Total 113 records.